CUAMC
YMAB

China Universal Asset Management Company’s Y-mAbs Therapeutics YMAB Stock Holding History

China Universal Asset Management Company’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,097
Closed -$41K – 513
2025
Q2 		$41K Buy
9,097
+113
+1% +$508 ﹤0.01% 428
2025
Q1 		$39.8K Sell
8,984
-513
-5% -$2.98K ﹤0.01% 432
2024
Q4 		$74.4K Buy
9,497
+925
+11% +$11.3K 0.01% 420
2024
Q3 		$113K Buy
8,572
+3,416
+66% +$43.3K 0.01% 348
2024
Q2 		$62.3K Sell
5,156
-3,234
-39% -$43.7K 0.01% 343
2024
Q1 		$136K Buy
8,390
+3,340
+66% +$45K 0.02% 339
2023
Q4 		$34.4K Buy
+5,050
New +$29.2K 0.01% 397
2022
Q4 		– Sell
-410
Closed -$6K – 474
2022
Q3 		$6K Buy
+410
New +$6.79K ﹤0.01% 263

Other funds holding YMAB

BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

China Universal Asset Management Company's YMAB Position: Q3 2025 in Review

China Universal Asset Management Company sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 9,097 shares — an estimated $41K sold.

China Universal Asset Management Company first reported a position in YMAB in Q3 2022 and held it in 8 quarters. The position peaked at $136K in Q1 2024. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

  • China Universal Asset Management Company reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
  • China Universal Asset Management Company sold 9,097 Y-mAbs Therapeutics shares in Q3 2025, an estimated $41K.
  • China Universal Asset Management Company first reported a position in Y-mAbs Therapeutics in Q3 2022 and held it in 8 quarters.
  • China Universal Asset Management Company's Y-mAbs Therapeutics position peaked at $136K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on China Universal Asset Management Company's 13F filing for Q3 2025, filed 10 Nov 2025.